Why Chemically Defined Cell Freezing Media Preserve CAR-T Viability, Recovery, and CAR Expression After Thaw
Cryopreservation is a decisive step in CAR-T and other cell therapy workflows. Between manufacturing, release testing, shipping, and clinical administration, engineered cells are frozen and thawed at least once, and every freeze-thaw cycle is an opportunity to lose viability, cell number, and, critically, the engineered function that makes the product therapeutic. For CAR-T cells, that […]
